Travere Therapeutics Inc
NASDAQ:TVTX
Travere Therapeutics Inc
NASDAQ:TVTX
Price:
29.72
USD
-3.76%
Market Closed
Market Cap:
$2.7B
Wall Street
Price Targets
TVTX Price Targets Summary
Travere Therapeutics Inc
Travere Therapeutics Inc
Wall Street analysts forecast TVTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
TVTX
is 43.57 USD
with a low forecast of 31.31 USD and a high forecast of 51.45 USD.
Lowest
Price Target
31.31
USD
5% Upside
Average
Price Target
43.57
USD
47% Upside
Highest
Price Target
51.45
USD
73% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TVTX's stock price target?
Price Target
43.57
USD
43.57
USD
According to Wall Street analysts, the average 1-year price target for
TVTX
is 43.57 USD
with a low forecast of 31.31 USD and a high forecast of 51.45 USD.
What is Travere Therapeutics Inc's Revenue forecast?
Projected CAGR
29%
29%
The
compound annual growth rate
of Travere Therapeutics Inc's revenue for the next 3 years is
29%.
